Enanta Pharmaceuticals is a clinical stage biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs for viral infections and liver diseases. Enanta’s research and development is currently focused on the following disease targets: respiratory syncytial virus (RSV), hepatitis B Virus (HBV), SARS-CoV-2 (COVID-19) and human metapneumovirus (hMPV).

Latest News

Read All

Events

See All